Abstract
Selection of cytostatic agents for intrathecal administration is the subject of this paper.
Both the toxic side effects—destruction of blood-brain barrier and change of body weight—and the cytostatic effects on intracranially transplanted Yoshida ascites sarcoma were investigated of intrathecal administration of various cytostatic agents. As a result, it may be concluded that Methotrexate and Endoxan and lower dose of mitomycin C are suitable drugs for intrathecal chemotherapy.
Based on these findings, clinical cases of malignant brain tumours were treated with intrathecal chemotherapy.
Grateful acknowledgement is made to Professor Dennosuke Jinnai for his constant interest and guidance in this investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hayakawa, T., Yamada, R., Kanai, N. et al. Intrathecal Chemotherapy. Br J Cancer 24, 489–497 (1970). https://doi.org/10.1038/bjc.1970.59
Issue Date:
DOI: https://doi.org/10.1038/bjc.1970.59
- Springer Nature Limited
This article is cited by
-
Interstitial chemotherapy for brain tumors: review
Journal of Neuro-Oncology (1991)